Global Vascular Malformations Drugs Market Growth 2022-2028
Vascular malformations are the kind of birthmark or growth, such as blemish or mass, that may cause pain, swelling, or bleeding. Vascular malformations often result from abnormal development in blood vessels, lymph vessels, veins, and arteries. Vascular malformations are usually present at birth; the abnormalities grow proportionally with the child. Vascular malformations are differentiated from vascular tumors based on endothelial proliferation.
The global market for Vascular Malformations Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Vascular Malformations Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Vascular Malformations Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Vascular Malformations Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Vascular Malformations Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Vascular Malformations Drugs players cover Galderma, Abbvie, Inc, Bausch Health Companies Inc, Bristol Myers Squibb Company and Fresenius Kabi AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Vascular Malformations Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Vascular Malformations Drugs market, with both quantitative and qualitative data, to help readers understand how the Vascular Malformations Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Vascular Malformations Drugs market and forecasts the market size by Type (Sirolimus, Glucocorticoids and Sclerotherapy), by Application (Lymphatic Malformations, Vascular Malformation and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Sirolimus
Glucocorticoids
Sclerotherapy
Segmentation by application
Lymphatic Malformations
Vascular Malformation
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Galderma
Abbvie, Inc
Bausch Health Companies Inc
Bristol Myers Squibb Company
Fresenius Kabi AG
Merck KGaA
Sanofi
F. Hoffmann-La Roche Ltd
Mylan N.V
Teva Pharmaceutical Industries Ltd
Pfizer Inc
GSK plc
Novartis AG
Accord Healthcare
Zydus Group
Dr Reddy's Laboratories Ltd
Amneal Pharmaceuticals LLC
Apotex Inc
Chapter Introduction
Chapter 1: Scope of Vascular Malformations Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Vascular Malformations Drugs market size (sales and revenue) and CAGR, Vascular Malformations Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Vascular Malformations Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Vascular Malformations Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Vascular Malformations Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Galderma, Abbvie, Inc, Bausch Health Companies Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, Merck KGaA, Sanofi, F. Hoffmann-La Roche Ltd and Mylan N.V, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vascular Malformations Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vascular Malformations Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vascular Malformations Drugs by Country/Region, 2017, 2022 & 2028
2.2 Vascular Malformations Drugs Segment by Type
2.2.1 Sirolimus
2.2.2 Glucocorticoids
2.2.3 Sclerotherapy
2.3 Vascular Malformations Drugs Sales by Type
2.3.1 Global Vascular Malformations Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Vascular Malformations Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vascular Malformations Drugs Sale Price by Type (2017-2022)
2.4 Vascular Malformations Drugs Segment by Application
2.4.1 Lymphatic Malformations
2.4.2 Vascular Malformation
2.4.3 Other
2.5 Vascular Malformations Drugs Sales by Application
2.5.1 Global Vascular Malformations Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Vascular Malformations Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vascular Malformations Drugs Sale Price by Application (2017-2022)
3 Global Vascular Malformations Drugs by Company
3.1 Global Vascular Malformations Drugs Breakdown Data by Company
3.1.1 Global Vascular Malformations Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Vascular Malformations Drugs Sales Market Share by Company (2020-2022)
3.2 Global Vascular Malformations Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Vascular Malformations Drugs Revenue by Company (2020-2022)
3.2.2 Global Vascular Malformations Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Vascular Malformations Drugs Sale Price by Company
3.4 Key Manufacturers Vascular Malformations Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vascular Malformations Drugs Product Location Distribution
3.4.2 Players Vascular Malformations Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vascular Malformations Drugs by Geographic Region
4.1 World Historic Vascular Malformations Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Vascular Malformations Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vascular Malformations Drugs Annual Revenue by Geographic Region
4.2 World Historic Vascular Malformations Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Vascular Malformations Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vascular Malformations Drugs Annual Revenue by Country/Region
4.3 Americas Vascular Malformations Drugs Sales Growth
4.4 APAC Vascular Malformations Drugs Sales Growth
4.5 Europe Vascular Malformations Drugs Sales Growth
4.6 Middle East & Africa Vascular Malformations Drugs Sales Growth
5 Americas
5.1 Americas Vascular Malformations Drugs Sales by Country
5.1.1 Americas Vascular Malformations Drugs Sales by Country (2017-2022)
5.1.2 Americas Vascular Malformations Drugs Revenue by Country (2017-2022)
5.2 Americas Vascular Malformations Drugs Sales by Type
5.3 Americas Vascular Malformations Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vascular Malformations Drugs Sales by Region
6.1.1 APAC Vascular Malformations Drugs Sales by Region (2017-2022)
6.1.2 APAC Vascular Malformations Drugs Revenue by Region (2017-2022)
6.2 APAC Vascular Malformations Drugs Sales by Type
6.3 APAC Vascular Malformations Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vascular Malformations Drugs by Country
7.1.1 Europe Vascular Malformations Drugs Sales by Country (2017-2022)
7.1.2 Europe Vascular Malformations Drugs Revenue by Country (2017-2022)
7.2 Europe Vascular Malformations Drugs Sales by Type
7.3 Europe Vascular Malformations Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vascular Malformations Drugs by Country
8.1.1 Middle East & Africa Vascular Malformations Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vascular Malformations Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Vascular Malformations Drugs Sales by Type
8.3 Middle East & Africa Vascular Malformations Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vascular Malformations Drugs
10.3 Manufacturing Process Analysis of Vascular Malformations Drugs
10.4 Industry Chain Structure of Vascular Malformations Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vascular Malformations Drugs Distributors
11.3 Vascular Malformations Drugs Customer
12 World Forecast Review for Vascular Malformations Drugs by Geographic Region
12.1 Global Vascular Malformations Drugs Market Size Forecast by Region
12.1.1 Global Vascular Malformations Drugs Forecast by Region (2023-2028)
12.1.2 Global Vascular Malformations Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vascular Malformations Drugs Forecast by Type
12.7 Global Vascular Malformations Drugs Forecast by Application
13 Key Players Analysis
13.1 Galderma
13.1.1 Galderma Company Information
13.1.2 Galderma Vascular Malformations Drugs Product Offered
13.1.3 Galderma Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Galderma Main Business Overview
13.1.5 Galderma Latest Developments
13.2 Abbvie, Inc
13.2.1 Abbvie, Inc Company Information
13.2.2 Abbvie, Inc Vascular Malformations Drugs Product Offered
13.2.3 Abbvie, Inc Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbvie, Inc Main Business Overview
13.2.5 Abbvie, Inc Latest Developments
13.3 Bausch Health Companies Inc
13.3.1 Bausch Health Companies Inc Company Information
13.3.2 Bausch Health Companies Inc Vascular Malformations Drugs Product Offered
13.3.3 Bausch Health Companies Inc Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bausch Health Companies Inc Main Business Overview
13.3.5 Bausch Health Companies Inc Latest Developments
13.4 Bristol Myers Squibb Company
13.4.1 Bristol Myers Squibb Company Company Information
13.4.2 Bristol Myers Squibb Company Vascular Malformations Drugs Product Offered
13.4.3 Bristol Myers Squibb Company Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bristol Myers Squibb Company Main Business Overview
13.4.5 Bristol Myers Squibb Company Latest Developments
13.5 Fresenius Kabi AG
13.5.1 Fresenius Kabi AG Company Information
13.5.2 Fresenius Kabi AG Vascular Malformations Drugs Product Offered
13.5.3 Fresenius Kabi AG Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Fresenius Kabi AG Main Business Overview
13.5.5 Fresenius Kabi AG Latest Developments
13.6 Merck KGaA
13.6.1 Merck KGaA Company Information
13.6.2 Merck KGaA Vascular Malformations Drugs Product Offered
13.6.3 Merck KGaA Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Merck KGaA Main Business Overview
13.6.5 Merck KGaA Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Vascular Malformations Drugs Product Offered
13.7.3 Sanofi Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 F. Hoffmann-La Roche Ltd
13.8.1 F. Hoffmann-La Roche Ltd Company Information
13.8.2 F. Hoffmann-La Roche Ltd Vascular Malformations Drugs Product Offered
13.8.3 F. Hoffmann-La Roche Ltd Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.8.5 F. Hoffmann-La Roche Ltd Latest Developments
13.9 Mylan N.V
13.9.1 Mylan N.V Company Information
13.9.2 Mylan N.V Vascular Malformations Drugs Product Offered
13.9.3 Mylan N.V Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan N.V Main Business Overview
13.9.5 Mylan N.V Latest Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Teva Pharmaceutical Industries Ltd Company Information
13.10.2 Teva Pharmaceutical Industries Ltd Vascular Malformations Drugs Product Offered
13.10.3 Teva Pharmaceutical Industries Ltd Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.10.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.11 Pfizer Inc
13.11.1 Pfizer Inc Company Information
13.11.2 Pfizer Inc Vascular Malformations Drugs Product Offered
13.11.3 Pfizer Inc Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Pfizer Inc Main Business Overview
13.11.5 Pfizer Inc Latest Developments
13.12 GSK plc
13.12.1 GSK plc Company Information
13.12.2 GSK plc Vascular Malformations Drugs Product Offered
13.12.3 GSK plc Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 GSK plc Main Business Overview
13.12.5 GSK plc Latest Developments
13.13 Novartis AG
13.13.1 Novartis AG Company Information
13.13.2 Novartis AG Vascular Malformations Drugs Product Offered
13.13.3 Novartis AG Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Novartis AG Main Business Overview
13.13.5 Novartis AG Latest Developments
13.14 Accord Healthcare
13.14.1 Accord Healthcare Company Information
13.14.2 Accord Healthcare Vascular Malformations Drugs Product Offered
13.14.3 Accord Healthcare Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Accord Healthcare Main Business Overview
13.14.5 Accord Healthcare Latest Developments
13.15 Zydus Group
13.15.1 Zydus Group Company Information
13.15.2 Zydus Group Vascular Malformations Drugs Product Offered
13.15.3 Zydus Group Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Zydus Group Main Business Overview
13.15.5 Zydus Group Latest Developments
13.16 Dr Reddy's Laboratories Ltd
13.16.1 Dr Reddy's Laboratories Ltd Company Information
13.16.2 Dr Reddy's Laboratories Ltd Vascular Malformations Drugs Product Offered
13.16.3 Dr Reddy's Laboratories Ltd Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Dr Reddy's Laboratories Ltd Main Business Overview
13.16.5 Dr Reddy's Laboratories Ltd Latest Developments
13.17 Amneal Pharmaceuticals LLC
13.17.1 Amneal Pharmaceuticals LLC Company Information
13.17.2 Amneal Pharmaceuticals LLC Vascular Malformations Drugs Product Offered
13.17.3 Amneal Pharmaceuticals LLC Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Amneal Pharmaceuticals LLC Main Business Overview
13.17.5 Amneal Pharmaceuticals LLC Latest Developments
13.18 Apotex Inc
13.18.1 Apotex Inc Company Information
13.18.2 Apotex Inc Vascular Malformations Drugs Product Offered
13.18.3 Apotex Inc Vascular Malformations Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Apotex Inc Main Business Overview
13.18.5 Apotex Inc Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Vascular Malformations Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vascular Malformations Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Sirolimus
Table 4. Major Players of Glucocorticoids
Table 5. Major Players of Sclerotherapy
Table 6. Global Vascular Malformations Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Vascular Malformations Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Vascular Malformations Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Vascular Malformations Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Vascular Malformations Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Vascular Malformations Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Vascular Malformations Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Vascular Malformations Drugs Revenue by Application (2017-2022)
Table 14. Global Vascular Malformations Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Vascular Malformations Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Vascular Malformations Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Vascular Malformations Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Vascular Malformations Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Vascular Malformations Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Vascular Malformations Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Vascular Malformations Drugs Producing Area Distribution and Sales Area
Table 22. Players Vascular Malformations Drugs Products Offered
Table 23. Vascular Malformations Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Vascular Malformations Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Vascular Malformations Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Vascular Malformations Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Vascular Malformations Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Vascular Malformations Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Vascular Malformations Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Vascular Malformations Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Vascular Malformations Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Vascular Malformations Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Vascular Malformations Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Vascular Malformations Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Vascular Malformations Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Vascular Malformations Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Vascular Malformations Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Vascular Malformations Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Vascular Malformations Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Vascular Malformations Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Vascular Malformations Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Vascular Malformations Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Vascular Malformations Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Vascular Malformations Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Vascular Malformations Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Vascular Malformations Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Vascular Malformations Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Vascular Malformations Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Vascular Malformations Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Vascular Malformations Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Vascular Malformations Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Vascular Malformations Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Vascular Malformations Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Vascular Malformations Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Vascular Malformations Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Vascular Malformations Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Vascular Malformations Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Vascular Malformations Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Vascular Malformations Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Vascular Malformations Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Vascular Malformations Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Vascular Malformations Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Vascular Malformations Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Vascular Malformations Drugs
Table 67. Key Market Challenges & Risks of Vascular Malformations Drugs
Table 68. Key Industry Trends of Vascular Malformations Drugs
Table 69. Vascular Malformations Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Vascular Malformations Drugs Distributors List
Table 72. Vascular Malformations Drugs Customer List
Table 73. Global Vascular Malformations Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Vascular Malformations Drugs Sales Market Forecast by Region
Table 75. Global Vascular Malformations Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Vascular Malformations Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Vascular Malformations Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Vascular Malformations Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Vascular Malformations Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Vascular Malformations Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Vascular Malformations Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Vascular Malformations Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Vascular Malformations Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Vascular Malformations Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Vascular Malformations Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Vascular Malformations Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Vascular Malformations Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Vascular Malformations Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Vascular Malformations Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Vascular Malformations Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Vascular Malformations Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Vascular Malformations Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Galderma Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Galderma Vascular Malformations Drugs Product Offered
Table 95. Galderma Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Galderma Main Business
Table 97. Galderma Latest Developments
Table 98. Abbvie, Inc Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbvie, Inc Vascular Malformations Drugs Product Offered
Table 100. Abbvie, Inc Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Abbvie, Inc Main Business
Table 102. Abbvie, Inc Latest Developments
Table 103. Bausch Health Companies Inc Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Bausch Health Companies Inc Vascular Malformations Drugs Product Offered
Table 105. Bausch Health Companies Inc Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Bausch Health Companies Inc Main Business
Table 107. Bausch Health Companies Inc Latest Developments
Table 108. Bristol Myers Squibb Company Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Bristol Myers Squibb Company Vascular Malformations Drugs Product Offered
Table 110. Bristol Myers Squibb Company Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Bristol Myers Squibb Company Main Business
Table 112. Bristol Myers Squibb Company Latest Developments
Table 113. Fresenius Kabi AG Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Fresenius Kabi AG Vascular Malformations Drugs Product Offered
Table 115. Fresenius Kabi AG Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Fresenius Kabi AG Main Business
Table 117. Fresenius Kabi AG Latest Developments
Table 118. Merck KGaA Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck KGaA Vascular Malformations Drugs Product Offered
Table 120. Merck KGaA Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Merck KGaA Main Business
Table 122. Merck KGaA Latest Developments
Table 123. Sanofi Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Vascular Malformations Drugs Product Offered
Table 125. Sanofi Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. F. Hoffmann-La Roche Ltd Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. F. Hoffmann-La Roche Ltd Vascular Malformations Drugs Product Offered
Table 130. F. Hoffmann-La Roche Ltd Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. F. Hoffmann-La Roche Ltd Main Business
Table 132. F. Hoffmann-La Roche Ltd Latest Developments
Table 133. Mylan N.V Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Mylan N.V Vascular Malformations Drugs Product Offered
Table 135. Mylan N.V Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Mylan N.V Main Business
Table 137. Mylan N.V Latest Developments
Table 138. Teva Pharmaceutical Industries Ltd Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Teva Pharmaceutical Industries Ltd Vascular Malformations Drugs Product Offered
Table 140. Teva Pharmaceutical Industries Ltd Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Teva Pharmaceutical Industries Ltd Main Business
Table 142. Teva Pharmaceutical Industries Ltd Latest Developments
Table 143. Pfizer Inc Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Pfizer Inc Vascular Malformations Drugs Product Offered
Table 145. Pfizer Inc Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Pfizer Inc Main Business
Table 147. Pfizer Inc Latest Developments
Table 148. GSK plc Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. GSK plc Vascular Malformations Drugs Product Offered
Table 150. GSK plc Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. GSK plc Main Business
Table 152. GSK plc Latest Developments
Table 153. Novartis AG Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Novartis AG Vascular Malformations Drugs Product Offered
Table 155. Novartis AG Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Novartis AG Main Business
Table 157. Novartis AG Latest Developments
Table 158. Accord Healthcare Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Accord Healthcare Vascular Malformations Drugs Product Offered
Table 160. Accord Healthcare Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Accord Healthcare Main Business
Table 162. Accord Healthcare Latest Developments
Table 163. Zydus Group Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Zydus Group Vascular Malformations Drugs Product Offered
Table 165. Zydus Group Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Zydus Group Main Business
Table 167. Zydus Group Latest Developments
Table 168. Dr Reddy's Laboratories Ltd Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 169. Dr Reddy's Laboratories Ltd Vascular Malformations Drugs Product Offered
Table 170. Dr Reddy's Laboratories Ltd Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Dr Reddy's Laboratories Ltd Main Business
Table 172. Dr Reddy's Laboratories Ltd Latest Developments
Table 173. Amneal Pharmaceuticals LLC Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 174. Amneal Pharmaceuticals LLC Vascular Malformations Drugs Product Offered
Table 175. Amneal Pharmaceuticals LLC Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Amneal Pharmaceuticals LLC Main Business
Table 177. Amneal Pharmaceuticals LLC Latest Developments
Table 178. Apotex Inc Basic Information, Vascular Malformations Drugs Manufacturing Base, Sales Area and Its Competitors
Table 179. Apotex Inc Vascular Malformations Drugs Product Offered
Table 180. Apotex Inc Vascular Malformations Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 181. Apotex Inc Main Business
Table 182. Apotex Inc Latest Developments
List of Figures
Figure 1. Picture of Vascular Malformations Drugs
Figure 2. Vascular Malformations Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Malformations Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Vascular Malformations Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vascular Malformations Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Sirolimus
Figure 10. Product Picture of Glucocorticoids
Figure 11. Product Picture of Sclerotherapy
Figure 12. Global Vascular Malformations Drugs Sales Market Share by Type in 2021
Figure 13. Global Vascular Malformations Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Vascular Malformations Drugs Consumed in Lymphatic Malformations
Figure 15. Global Vascular Malformations Drugs Market: Lymphatic Malformations (2017-2022) & (K Units)
Figure 16. Vascular Malformations Drugs Consumed in Vascular Malformation
Figure 17. Global Vascular Malformations Drugs Market: Vascular Malformation (2017-2022) & (K Units)
Figure 18. Vascular Malformations Drugs Consumed in Other
Figure 19. Global Vascular Malformations Drugs Market: Other (2017-2022) & (K Units)
Figure 20. Global Vascular Malformations Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Vascular Malformations Drugs Revenue Market Share by Application in 2021
Figure 22. Vascular Malformations Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Vascular Malformations Drugs Revenue Market Share by Company in 2021
Figure 24. Global Vascular Malformations Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Vascular Malformations Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Vascular Malformations Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Vascular Malformations Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Vascular Malformations Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Vascular Malformations Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Vascular Malformations Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Vascular Malformations Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Vascular Malformations Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Vascular Malformations Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Vascular Malformations Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Vascular Malformations Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Vascular Malformations Drugs Sales Market Share by Country in 2021
Figure 37. Americas Vascular Malformations Drugs Revenue Market Share by Country in 2021
Figure 38. United States Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Vascular Malformations Drugs Sales Market Share by Region in 2021
Figure 43. APAC Vascular Malformations Drugs Revenue Market Share by Regions in 2021
Figure 44. China Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Vascular Malformations Drugs Sales Market Share by Country in 2021
Figure 51. Europe Vascular Malformations Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Vascular Malformations Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Vascular Malformations Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Vascular Malformations Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Vascular Malformations Drugs in 2021
Figure 65. Manufacturing Process Analysis of Vascular Malformations Drugs
Figure 66. Industry Chain Structure of Vascular Malformations Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets